N (%) OS: HR (95% CI, p-value) PFS: HR (95% CI, p-value) ORR: OR (95% CI, p-value) ...
The Conquer Cancer Young Investigator Award (YIA) provides funding to promising investigators to encourage and promote quality research in clinical oncology. YIA Special Competitions are open in ...
Physician burnout has increased significantly in the last decade and organizational strategies are vital to improve physician well-being, according to new research from the American Society of ...
The Association for Clinical Oncology (ASCO) is working to understand the extent and scope of several recent executive actions. ASCO recognizes the concern and confusion many are currently ...
Included article count by country.
On January 27, the Association for Clinical Oncology (ASCO) submitted comments in response to the Centers for Medicare & Medicaid Services (CMS) Contract Year (CY) 2026 Policy and Technical Changes to ...
On January 17, 2025, the Centers for Medicare & Medicaid Services (CMS) released the names of 15 additional drugs to be included in the next round of drug price negotiation under Medicare Part D, ...
Clinicopathologic data and pathologic analysis of tumor microenvironment in patients with non-recurrent vs. recurrent LGTa cancer.
No significant differences in BMI and PWC between treatment groups. Hazard ratios for PWC groups after adjusting for performance status, PDL1, and treatment in multivariate analysis.
The American Society of Clinical Oncology (ASCO) released a new position statement today detailing recommendations for health care stakeholders to reduce the heavy financial burden people with cancer ...
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback